Showing 1 - 10 of 143
Persistent link: https://www.econbiz.de/10012508485
Persistent link: https://www.econbiz.de/10012509084
Artificial intelligence (AI) and Machine learning (ML) systems in medicine are poised to significantly improve health care, for example, by offering earlier diagnoses of diseases or recommending optimally individualized treatment plans. However, the emergence of AI/ML in medicine also creates...
Persistent link: https://www.econbiz.de/10013224532
Direct-to-consumer medical artificial intelligence/machine learning applications are increasingly used for a variety of diagnostic assessments, and the emphasis on telemedicine and home healthcare during the COVID-19 pandemic may further stimulate their adoption. In this Perspective, we argue...
Persistent link: https://www.econbiz.de/10013220569
There has been increasing interest in the use of home monitoring technologies during the COVID-19 pandemic to decrease interpersonal contacts and the resultant risks of exposure for people to the coronavirus SARS-CoV-2. This Perspective explores how the accelerated development of these...
Persistent link: https://www.econbiz.de/10013226604
Artificial intelligence (AI) is quickly making inroads into medical practice, especially in forms that rely on machine learning, with a mix of hope and hype. Multiple AI-based products have now been approved or cleared by the US Food and Drug Administration (FDA), and health systems and...
Persistent link: https://www.econbiz.de/10013226627
The COVID-19 pandemic has highlighted that leveraging medical big data can help to better predict and control outbreaks from the outset. However, there are still challenges to overcome in the 21st century to efficiently use medical big data, promote innovation and public health activities and,...
Persistent link: https://www.econbiz.de/10013244043
Artificial intelligence (AI) is rapidly entering medical practice, whether for risk prediction, diagnosis, or treatment recommendation. But a persistent question keeps arising: What happens when things go wrong? When patients are injured, and AI was involved, who will be liable and how?...
Persistent link: https://www.econbiz.de/10013217536
Persistent link: https://www.econbiz.de/10012288990
This paper suggests a new normative approach for combining beliefs. We call it the evidence-first method. Instead of aggregating credences alone, as the prevailing approaches, we focus instead on eliciting a group's full probability distribution on the basis of the evidence available to its...
Persistent link: https://www.econbiz.de/10014084998